Gairhe S, Bauer NN, Gebb SA, McMurtry IF. Serotonin passes through myoendothelial gap junctions to promote pulmonary arterial smooth muscle cell differentiation.
pulmonary arteries; vascular; cell signaling ENDOTHELIAL CELLS (ECs) and smooth muscle cells (SMCs) work in concert to maintain the homeostasis of blood vessels (11) . These cells are coupled physically, electrically, and metabolically through gap junctions. Gap junctions are ubiquitous intercellular channels that connect the cytoplasm of adjacent cells. These channels are ϳ30 Å in diameter and permit free movement of metabolites smaller than 1.2 kDa (14, 30, 52) . Gap junctions that directly connect the interiors of ECs and SMCs are known as myoendothelial gap junctions (52, 53) . The myoendothelial intercellular interaction is bidirectional and regulates the structural and functional status of the vasculature (55) . An interesting and critical phenomenon of EC-SMC interaction is the regulation of vascular tone and control of blood pressure. The contraction and relaxation of SMCs determines vascular tone, and these processes are controlled, in part, by the release of vasoconstrictors and dilators from ECs (59) and possibly by signals transmitted through myoendothelial gap junctions (1, 13, 16) .
The phenotype of ECs and SMCs is affected by the presence of the other. Quiescent ECs support the differentiated (contractile) phenotype of SMCs, and activated ECs promote the dedifferentiated (synthetic) phenotype (6) . Similarly, the functional state of ECs is significantly changed in the presence of synthetic SMCs. Synthetic SMCs release chemokines, cytokines, and growth factors that activate ECs to, in turn, increase the secretion of chemokines and growth factors and the expression of cell adhesion molecules (9, 22) . Normal ECs maintain the differentiated phenotype of SMCs by protecting underlying SMCs from direct exposure to serum and circulating growth factors (57) . On the other hand, dysfunctional ECs are involved in SMC phenotypical changes associated with vascular remodeling in pulmonary arterial hypertension (5) . Therefore, EC-SMC interaction is critically and equally important during physiological as well as pathological conditions. However, it remains unclear exactly how and what kind of normal and abnormal EC-derived signals are relayed to SMCs and vice versa.
Several studies with both systemic and pulmonary arterial cells show that coculture with ECs can induce differentiation of SMCs (8, 20, 21, 28, 60) . Hirshi et al. observed that gap junctional communication between cocultured ECs and progenitor mesenchymal cells mediated the activation of TGF-␤ and consequent mural cell differentiation (27) . Similarly, we have recently found that coculture of pulmonary arterial ECs (PAECs) with pulmonary arterial SMCs (PASMCs) results in formation of myoendothelial gap junctions, which induce activation of TGF-␤ signaling and differentiation of the PASMCs toward a contractile phenotype (21) . However, the PAECderived signaling molecule that passes through the myoendothelial gap junctions has not been identified. This molecule should be 1) small enough to pass through gap junctions, 2) synthesized in PAECs, and 3) able to promote PASMC differentiation.
Among the numerous factors produced by PAECs, serotonin, which is synthesized from the amino acid L-tryptophan by tryptophan hydroxylase (Tph) and aromatic L-amino acid decarboxylase in two successive steps, meets the criteria of the unidentified signaling molecule, because it 1) is a small (176 Da) molecule that passes through neuronal gap junctions (64) , 2) is synthesized by human PAECs but not PASMCs (15) , and 3) can stimulate differentiation of PASMCs (12) . Therefore, this study tests the hypothesis that serotonin is the mediator of PAEC-induced myoendothelial gap junction-dependent activation of TGF-␤ signaling and differentiation of PASMCs.
Utilizing previously established coculture conditions (21) , this study shows that 1) rat PAECs but not PASMCs synthesize serotonin, 2) PAEC-derived serotonin passes through myoendothelial gap junctions into PASMCs, and 3) PAEC-derived serotonin activates TGF-␤ signaling and promotes PASMC differentiation. Thus this study identifies a novel serotoninmediated signaling pathway by which PAECs can regulate PASMC phenotype.
MATERIALS AND METHODS
Cell culture and treatments. To determine the role of endogenous serotonin signaling in the PAEC-induced myoendothelial-dependent differentiation of PASMCs, Sprague-Dawley rat proximal PAECs and PASMCs were cultured alone (monocultured), cocultured on opposite sides of a porous Transwell membrane (touch coculture), or PAECs were cultured on the bottom of a six-well plate and PASMCs on the Transwell membrane (no-touch coculture) as previously described (21) . PASMCs were also touch cocultured with PASMCs. For touch cocultures, respective cells were cocultured on opposite sides of Transwell insert (Corning) with a 10-m-thick polyethylene terephthalate membrane containing 0.4-m-diameter pores and a surface area of 4.2 cm 2 . The 0.4-m-diameter pores of the Transwell membrane permit direct cell-cell contact and formation of myoendothelial gap junctions between the touch cocultured cells but restrict cell migration. In contrast, PAECs and PASMCs do not form direct cell-cell contacts but can exchange soluble factors across the porous insert membrane in no-touch coculture.
PAECs and PASMCs were cocultured in low-serum medium (DMEM ϩ 2% FBS) for 24 h before drug treatment. Low-serum medium was replaced with growth arrest medium (DMEM ϩ 0.1% FBS for PAECs, and DMEM-F12 50:50 for PASMCs), for 48 h. PAECs were then treated with either the gap junction blocker carbenoxolone (100 mol/l, Sigma) (51), the inhibitor of tryptophan hydroxylase, para-chloro-phenyl-alanine (PCPA) (10 mol/l, Tocris) (33), DMSO (0.1% vol/vol, vehicle control), or left untreated for the next 24 h of incubation at 37°C in air plus 5% CO 2. PASMCs in PAEC/ PASMC touch cocultures and in monoculture were also treated for 24 h with the serotonin transporter inhibitor fluoxetine (1 mol/l, Sigma) (46, 48) . Cells were then processed for morphological and biochemical analysis. Each experiment was independently repeated 3-5 times.
Real-time PCR. To determine whether PAECs and PASMCs can synthesize serotonin, the transcript levels of Tph1, the rate-limiting enzyme in serotonin synthesis, was assessed in monocultured and cocultured PAECs and PASMCs, using real-time PCR. Briefly, total RNA was extracted with Trizol (Qiagen) and purified using the RNeasy mini kit (Qiagen). Genomic DNA contaminants were removed by an optional on-column DNase digestion step using the RNase-Free DNase Set (Qiagen). Total RNA concentration was determined using a Nano-drop Spectrophotometer ND-1000, and RNA quality was estimated by the absorbance ratio of 260/280 and 260/230. Ten nanograms of total RNA were used as template, and RT-PCR was performed with the iScript One-Step RT-PCR Kit with SYBR Green (Bio-Rad) utilizing the iQ5 Real-Time Detection System (Bio-Rad). Primers for Tph1 and GAPDH (Table 1) were designed from 5= to 3= according to established guidelines. GAPDH transcript level served as an internal reference control for normalization of the relative level of Tph1 expression. Relative expression was calculated using the 2 Ϫ⌬CT method (54). Each experiment was repeated three times for monocultured cells and six times for touch and no-touch cocultures.
Immunocytochemistry. To detect the presence of serotonin in touch and no-touch PAEC/PASMC cocultures and in touch PASMC/ PASMC cocultures, the PAEC and PASMC monolayers were immunostained for serotonin. After 48 h of coculture, the medium was removed, and the cells were washed with PBS, fixed with 2% paraformaldehyde, permeabilized with 0.1% Triton X-100 in PBS, blocked with 5% normal donkey serum and BSA in PBS, and incubated with rabbit anti-serotonin primary antibody (1:50 dilution, Neuromics). Following three washes with PBS, the cells were incubated with a fluorescent-labeled anti-rabbit secondary antibody Alexa Fluor 594 for PAECs and Alexa Fluor 488 for PASMCs (Invitrogen). To confirm the identity of the cells in coculture, after 3 washes, PAECs and PASMCs were counterstained/reprobed with goat anti-PECAM-1 (1:500, Santa Cruz Biotechnology) and mouse anti-␣-SMC actin primary antibody (1:1,000 dilution, Sigma), respectively. Cells were further incubated with Alexa Fluor 488-conjugated antigoat and Alexa Fluor 594-conjugated anti-mouse secondary antibody for PAECs and PASMCs, respectively. As a negative control, cells were incubated with only secondary antibody or with primary antibody preabsorbed with antigen whenever appropriate. In all cases, antibody selectivity was assessed by Western blotting. The fluorescence in the cells was visualized with a Nikon Eclipse TE2000-E. The fluorescence intensity of serotonin in the cells was measured by the program NIS-Elements AR 3.22.00 (Build 710). In each experimental group, at least 30 different cells were analyzed, and data are represented as means Ϯ SE of intensity of pixels.
Western blot. After treatment with drug or vehicle, or left untreated, as described above, the PAEC and PASMC monolayers from PAEC/ PASMC cocultures or PASMC monocultures were harvested with lysis buffer containing 0.1% SDS and 1% Triton X-100 and processed for Western blot analysis as described previously (21) . The Western blot was performed for Tph1 (Tph1, 1:200, Abcam) in PAECs and for the SMC contractile proteins myosin heavy chain (MHC, 1:1,000 dilution, Biomedical Technologies) and calponin (1:4,000 dilution, Sigma) as well as p-SMAD 2 (1:1,000 dilution, Cell Signaling) in PASMCs. Immunoblots were detected by chemiluminescent assay using a Super Signal Kit (Pierce) and exposed to clear blue X-ray film (Pierce) or using a Fuji film LAS-1000 imaging system. The blots were then stripped (Restore Western blot Stripping buffer, Pierce), reprobed with primary antibody to GAPDH (1:1,000 dilution, Cell Signaling), or ␣-tubulin (1:1,000 dilution, Sigma), and processed and developed as described above. Because of the similarity in molecular weights of GAPDH (37 kDa) and calponin (34 kDa), we used either GAPDH, ␣-tubulin (55 kDa), or ␤-actin (43 kDa) as the loading control whenever appropriate. Densitometric analysis of protein bands was performed with Fuji Image Gauge software v.4.0. Band intensities were measured by calculating the ratio of protein of interest/ internal control. Data are presented as percentage of control (set as 100). All experiments were repeated at least three times.
Knockdown of connexin 43 and Tph1 by siRNA. To further test the role of myoendothelial gap junctions and serotonin in the PAECdependent modulation of PASMC phenotype, and to rule out possible nonselective effects of the pharmacological inhibitors carbenoxolone and PCPA, the gap junctional protein connexin 43 (Cx-43) and the rate-limiting enzyme in serotonin synthesis, Tph1, were specifically knocked down in PAECs by siRNA. PAECs and PASMCs typically express only Cx-43, -40, and -37 (3) . Using quantitative RT-PCR, immunocytochemistry, and Western blot analysis, we have previously shown that Cx-43 and -40 are present in both in PAECs and PASMCs, whereas Cx-37 was only present in PASMCs (21). Because both transcript and protein levels for Cx-43 were distinct and highly Animal. Normal adult male Sprague-Dawley rats (n ϭ 5, 315 Ϯ 39 g; Harlan Laboratories) were anesthetized with Nembutal (50 mg/kg) and euthanized by exsanguination. The lungs and pulmonary and systemic arteries were isolated for immunostaining. All procedures involving the animals were approved by the University of South Alabama Animal Care and Use Committee.
Immunohistochemical staining. Rat lungs were inflated with formalin (10%) at a constant pressure of 20 cm H2O. Rings of extralobar pulmonary artery were cut and fixed in formalin. Formalin-fixed samples were paraffin embedded, and 5-m-thick tissue sections were deparaffinized and rehydrated. The activity of endogenous peroxides was blocked with hydrogen peroxide for 10 min. After heat-activated epitope retrieval with citrate buffer treatment for 30 min, the sections were blocked with normal horse serum for 1 h. Serial sections were then incubated overnight at 4°C with either polyclonal rabbit antiTph1 antibody (1:500 dilution, Santa Cruz Biotechnology) or anti-von Willebrand factor antibody (1:100 dilution, Dako) or anti-serotonin antibody (1:100 dilution, Neuromics). After being washed with PBS, the sections were incubated with biotinylated secondary antibodies for 30 min, washed with PBS, and incubated in ABC Regent for another 30 min. Antibody selectivity was assessed using Western blot analysis. Negative control was performed using a rabbit IgG isotype instead of primary antibody. Positive staining was visualized as brown staining with diaminobenzidine (2) as a substrate for the horseradish peroxidase. Sections were counterstained with hematoxylin and analyzed by light microscopy.
Electron microscopy. The left lung was harvested from a normal rat and processed for electron microscopy as described elsewhere (65) . Lungs were fixed in 3% glutaraldehyde constituted in cacodylate buffer. Lung tissue was sectioned into 1-mm 3 blocks and rinsed in cacodylate buffer. Tissues were then postfixed for 1 h with 1% osmium tetroxide, dehydrated using a graded alcohol series, and embedded in PolyBed 812 resin (Polysciences). Thin sections (80 nm) were cut from each block with a diamond knife. Sections were stained with uranyl acetate and counterstained with Reynold's lead citrate. Sections were examined and photographed using a Philips CM 100 transmission electron microscope (FEI).
Data analysis and statistical methods. Data were obtained from at least three independent experiments, and statistical analysis was performed by unpaired t-test or one-way ANOVA followed by post hoc testing with Dunnett's test using GraphPad Prism software v.5.0.
Data are expressed as means Ϯ SE. Significance was denoted at P Ͻ 0.05.
RESULTS

Tph1 is predominantly expressed in PAECs.
To determine whether serotonin synthesis was restricted to PAECs, we measured the mRNA levels of Tph1, the rate-limiting enzyme in serotonin synthesis, in PAECs and PASMCs in monoculture, no-touch coculture, and touch coculture. Quantitative RT-PCR of total RNA of PAECs and PASMCs from the various culture types showed that Tph1 expression was higher in PAECs than in PASMCs (Fig. 1) . This observation is similar to that reported by Eddahibi et al. (15) , in which human PAECs but not PASMCs expressed Tph1. The very low level of expression of Tph1 in PASMCs was uniform across the culture types, whereas expression of Tph1 in PAECs was variable, being highest in monoculture, moderate in touch coculture, and lower in no-touch coculture. These findings suggest that serotonin is synthesized in PAECs but not PASMCs.
PAEC-derived serotonin is transferred from PAECs to PASMCs in PAEC/PASMC touch coculture. We next examined whether serotonin synthesized in PAECs was transferred to PASMCs and whether the intercellular transfer required direct cell-cell contact. Immunostaining for serotonin was performed in PAECs and PASMCs in PAEC/PASMC touch and no-touch cocultures and in PASMCs in PASMC/PASMC touch coculture. Consistent with the Tph1 mRNA expression data ( Fig. 1) , serotonin was detected in PAECs in both PAEC/PASMC touch and no-touch cocultures (Fig. 2, A and B) . Interestingly, serotonin was also detected in PASMCs in the PAEC/PASMC touch but not the no-touch coculture (Fig. 2, D and E) . The monoamine was not detected in PASMCs in the PASMC/ PASMC touch coculture (Fig. 2, C and F) . These results support the idea that serotonin is synthesized by PAECs but not PASMCs and also show that the monoamine is transferred from PAECs to PASMCs only in the presence of direct cell-cell contact.
PAEC-derived serotonin passes from PAECs into PASMCs via myoendothelial gap junctions. We have previously shown that touch cocultured PAECs and PASMCs form functional myoendothelial gap junctions (21) . To test whether serotonin synthesized in PAECs passes into PASMCs via myoendothelial gap junctions in PAEC/PASMC touch coculture, we inhibited gap junctional communication with the blocker carbenoxolone (51) . After 24 h of carbenoxolone treatment, the PAEC and PASMC monolayers in PAEC/PASMC touch coculture were immunostained for serotonin. We detected no difference in serotonin staining in vehicle control and carbenoxolonetreated PAECs (Fig. 3, A, E, and K) . However, there was a marked decrease in serotonin staining in the PASMCs of carbenoxolone-treated cocultures (Fig. 3, F and K) compared with the vehicle control cocultures (Fig. 3, B and K) .
In addition to the nonselective gap junction inhibitor carbenoxolone, we used siRNA in PAECs to selectively knockdown the predominant gap junctional protein Cx-43. Serotonin staining was quantified in both Cx-43 knocked down-PAECs and PASMCs in PAEC/PASMC coculture. Compared with the nontargeting siRNA control (Fig. 3C) , there was no change in serotonin staining in Cx-43 knocked down-PAECs (Fig. 3G) . Conversely, compared with nontargeting siRNA control (Fig.  3D) , serotonin staining was decreased by ϳ60% in the cocultured PASMCs (Fig. 3H) . In contrast, exposure of the PAEC/ PASMC touch coculture to fluoxetine, an inhibitor of the serotonin transporter that significantly reduced (40 Ϯ 5%) the uptake of exogenous serotonin by monocultured PASMCs, had no effect on the level of monoamine staining in the cocultured PASMCs (Fig. 3 , J and K) compared with PASMCs in vehicletreated coculture (Fig. 3, B and K) . These observations indicate that PAEC-derived serotonin is transferred from PAECs directly into PASMCs via myoendothelial gap junctions in PAEC/PASMC touch coculture.
Inhibition of serotonin synthesis in PAECs reduces TGF-␤ signaling and differentiation of PASMCs in PAEC/PASMC touch coculture. We have previously shown that activation of TGF-␤ signaling is involved in the myoendothelial gap junctiondependent differentiation of PASMCs to a more contractile-like phenotype in PAEC/PASMC touch coculture (21) . Therefore, we investigated whether PAEC-derived serotonin was responsible for the activation of TGF-␤ signaling and induction of differentiation of PASMCs. We inhibited serotonin synthesis in PAECs by inhibiting Tph1 with PCPA and by knocking down Tph1 expression with siRNA. Exposure of PAECs to PCPA reduced PASMC expression of p-SMAD 2 (Fig. 4A) proteins MHC (Fig. 4B) and calponin (Fig. 4C ) in PAEC/ PASMC touch coculture. Similarly, ϳ90% knockdown of Tph1 in PAEC by siRNA (Fig. 4D) , not only reduced serotonin expression in PAECs (data not shown), but also reduced the levels of p-SMAD 2 (Fig. 4E), MHC (Fig. 4F) , and calponin (Fig. 4G ) in the PASMCs of PAEC/PASMC touch cocultures. These findings support the idea that serotonin synthesized in PAECs is the myoendothelial gap junction-dependent signal that activates TGF-␤ signaling and promotes a more differentiated phenotype of PASMCs in PAEC/PASMC touch coculture.
Expression of Tph1 and serotonin in pulmonary arteries.
To explore whether Tph1 expression is also confined to PAECs in vivo, we immunostained sections of normal rat extralobar pulmonary artery and lung. Tph1 expression was detected in PAECs but not in PASMCs of extralobar (Fig. 5A ), proximal muscular (Fig. 5B) , and distal partially muscular (Fig. 5C ) pulmonary arteries. Presence of Tph1 staining in the endothelial layer of these pulmonary arteries was supported by similar localization of the endothelial marker protein von Willebrand factor in serial sections (Fig. 5, D-F human pulmonary arteries and support the idea that the expression of Tph1 and synthesis of serotonin only in PAECs is not an artifact of cell culture. In contrast to the PAEC-specific localization of Tph1, immunostaining of serial sections for serotonin showed that the monoamine was present in both the EC and SMC layers of extralobar, proximal muscular, and distal partially muscular pulmonary arteries (Fig. 5, G-I) . Presence of myoendothelial junctions in pulmonary arteries. Proximal muscular and distal partially muscular pulmonary arteries in rat lung sections were assessed for the presence of immunoblots and densitometric analysis of Tph1 were normalized to GAPDH. E: immunoblots and densitometric analysis of p-SMAD 2 was normalized to GAPDH. F: immunoblots and densitometric analysis of MHC were normalized to GAPDH. Data are from 3 to 5 independent experiments with means Ϯ SE. *P Ͻ 0.05 relative to nontargeting. G: immunoblots and densitometric analysis of calponin were normalized to ␤-actin. Data are from 4 independent experiments with means Ϯ SE. *P Ͻ 0.05 relative to nontargeting.
myoendothelial junctions by electron microscopy. It was observed that myoendothelial junctions physically connected PAECs and PASMCs in both the proximal (Fig. 6, A and B) and distal (Fig. 6, C and D) pulmonary arteries. Thus PAECderived serotonin signaling via myoendothelial gap junctions may be a novel signaling pathway involved in PAEC-PASMC communication in vivo.
DISCUSSION
This study identifies serotonin as the signaling molecule that mediates PAEC-induced, myoendothelial gap junction-dependent activation of TGF-␤ signaling and differentiation of PASMCs to a more contractile-like phenotype in PAEC/ PASMC coculture. We found that 1) PAECs but not PASMCs synthesized serotonin, 2) the transfer of serotonin from PAECs directly into cocultured PASMCs depended on functional myoendothelial gap junctions, and 3) inhibition of serotonin synthesis in PAECs or blockade of its transfer from PAECs into PASMCs through gap junctions inhibited the PAECinduced activation of TGF-␤ signaling and differentiation of the PASMCs.
Although paracrine signaling and direct cell-cell contact between arterial ECs and SMCs have been shown in numerous studies to regulate the phenotype of SMCs (4, 10, 15, 18, 19, 26, 27, 31, 32, 34) , the signals exchanged during the direct cell-cell contact have not been fully defined. Using the EC/ SMC coculture system established by Isakson communication between the cocultured cells was blocked by pharmacological inhibitors or genetic ablation of the gap junctional protein Cx-43, the differentiation of PASMCs was prevented. Additionally, we found that the myoendothelial gap junction-dependent differentiation of PASMCs was mediated at least partly by TGF-␤ signaling (21) . However, the PAECderived signaling molecule passing through the myoendothelial gap junctions was not identified. Because serotonin is a small (176 Da) molecule that passes through neuronal gap junctions (64) , is synthesized by human PAECs but not PASMCs (15) , and influences PASMC plasticity (12, 37), we hypothesized that it is the signaling molecule in PAEC-induced, myoendothelial gap junction-dependent differentiation of PASMCs.
Consistent with the findings of Eddahibi et al. (15) in human pulmonary arterial cells, we observed a predominant expression of Tph1 mRNA in rat PAECs compared with rat PASMCs. Whereas the negligible expression of Tph1 in PASMCs was constant across culture conditions, Tph1 expression in PAECs was high in monoculture, moderate in touch coculture, and low in no-touch coculture. We did not pursue this observation, but it suggests that Tph1 expression in PAECs may be negatively regulated by PASMCs through paracrine signaling.
Distinct cytosolic serotonin staining was detected in PAECs in both touch and no-touch PAEC/PASMC cocultures, but the monoamine was found in PASMCs only when they were in direct contact with PAECs. Failure to detect serotonin staining in PASMCs in PAEC/PASMC no-touch coculture and in PASMC/PASMC touch coculture strongly supported that serotonin was synthesized in PAECs and transferred directly to PASMCs. Inhibition of this transfer by blockade of myoendothelial gap junctions with either carbenoxolone or genetic ablation of Cx-43, but not by blockade of the serotonin transporter with fluoxetine, indicated the PAEC-derived monoamine was transferred directly into PASMCs via myoendothelial gap junctions, rather than by extracellular release and reuptake. That PAEC-derived serotonin was the myoendothelial gap junction-dependent factor responsible for signaling the differentiation of PASMCs was supported by the findings that inhibition of serotonin synthesis in PAECs reduced monoamine staining, phosphorylation of the TGF-␤ signaling marker SMAD 2, and expression of the contractile proteins MHC and calponin in the touch cocultured PASMCs.
Depending on the species and vessel of origin of the cells, and the concentration and duration of exposure to the monoamine, exogenous serotonin can exert a multitude of effects on vascular SMCs, including cell contraction, relaxation, migration, hypertrophy, and proliferation (1, 12, 17, 38, 61) . These diverse responses are mediated by a variety of cell signaling pathways elicited by stimulation of various serotonin receptor subtypes and/or the internalization of the monoamine by its transporter. Although there are several reports of serotonininduced proliferation of PASMCs isolated from a variety of species (17, 35, 36, 40, 43, 56, 63) , Deng et al. (12) recently found in human PASMCs that serotonin increased cell size, contractile protein expression, and contractility but did not stimulate DNA synthesis. This supports our finding that the PAEC-derived, myoendothelial gap junction-transferred serotonin in PAEC/PASMC coculture promoted differentiation of the PASMCs.
We have previously shown that PAEC-induced, myoendothelial gap junction-dependent differentiation of PASMCs is associated with activation of latent TGF-␤ and increased phosphorylation of SMAD 2 and is inhibited by TGF-␤ type I receptor blockade (21) . Similarly, in this study, the PAECderived serotonin-induced differentiation of PASMCs was associated with increased phosphorylation of SMAD 2, which implicates the involvement of TGF-␤ signaling. The regulation of SMC phenotype is complex and multifactorial (45, 49) , and exactly how serotonin stimulates contractile protein expression remains to be defined. Whether or not the PAEC-derived serotonin was directly involved in the activation of latent TGF-␤ is unknown and will require further study. However, recent reports of transglutaminase-mediated serotonylation of several signaling and contractile proteins in arterial SMCs (23, 41, 62) and our observation of a close association of the serotonin with smooth muscle actin-␣ filaments in the PASMCs (data not shown) raise the possibility that a serotonin-induced increase in cellular mechanical tension plays a role (44) .
To investigate whether selective expression of Tph1 and serotonin synthesis in PAECs was limited to in vitro coculture, Tph1 expression and serotonin staining were examined in extralobar pulmonary arteries and lung sections of normal rats. Consistent with the findings in cell culture, Tph1 staining was detected only in the endothelial layer of large and small pulmonary arteries, and serotonin staining was positive in both intima and media. Failure to detect Tph1 staining in the smooth muscle layer supports the idea that serotonin is synthesized in PAECs but not PASMCs of normal rat pulmonary arteries. These findings agree with previous observations that Tph1 immunostaining is confined to the intima of both normotensive and hypertensive human pulmonary arteries (15) and the hypertensive pulmonary arteries of chronically hypoxic mice (Tph1 immunostaining was not observed in normotensive mouse pulmonary arteries) (42) .
To confirm the previously reported presence of myoendothelial junctions in pulmonary arteries (50), we examined rat lung sections by electron microscopy. PAECs and PASMCs were found to interact directly with each other by sending cellular projections through gaps in the internal elastic lamina in both proximal and distal pulmonary arteries. Whether or not these myoendothelial connections actually contain functional gap junctions remains to be determined, but their presence and the PAEC-restricted expression of Tph1 in intact pulmonary arteries support an in vivo relevance of our coculture findings.
A limitation of our study is that the PAECs were not exposed to flow-induced shear stress during the PAEC/PASMC coculture. Exposure of ECs to shear stress has important effects on the interactions between cocultured ECs and SMCs (24, 25, 47, 58) , and it is uncertain how exposure to flow would have affected the serotonin signaling in the PAEC/PASMC cocultures. In this regard, Li et al. (39) have observed that exposure of bovine PAECs to high levels of flow leads to increased expression of ␣-actin and MHC without stimulating DNA synthesis in cocultured PASMCs, and it would be interesting to determine whether this response is mediated by PAEC-derived serotonin. The absence of flow in our PAEC/PASMC cocultures was clearly not responsible for the PAEC-selective expression of Tph1 because this was also observed in the pulmonary arterial samples. Another issue is that the cells used in our study were derived from conduit pulmonary arteries and might not fully reflect the behavior of resistance arterial cells, although small, partially muscular pulmonary arteries in the sections of rat lung did show EC-restricted immunostaining for Tph1 and the presence of serotonin in both endothelial and smooth muscle layers. Finally, although this and our earlier study (21) clearly show that functional myoendothelial gap junctions are required for the PAEC-induced activation of TGF-␤ and differentiation of the cocultured PASMCs, we have not directly ruled out a role for serotonin receptor signaling. Additional studies will be required to identify which receptors are expressed by the PASMCs and then test whether or not knocking them down impacts the response to the PAECderived serotonin. However, the absence of TGF-␤ activation in the no-touch cocultures from our earlier study (21) suggests that PAEC-secreted, extracellular serotonin is not sufficient to elicit the response.
In summary, the differentiation of PASMCs in PAEC/ PASMC coculture involves transfer of serotonin from PAECs into PASMCs via myoendothelial gap junctions and the activation of TGF-␤ signaling (Fig. 7) . The possibility of serotonin transporter-mediated signaling is ruled out by the lack of effect of the inhibitor fluoxetine and the absence of effect in no-touch coculture. Although the exact mechanism by which PAECderived serotonin activates PASMC TGF-␤ signaling and differentiation remains to be explored, this study provides new insights on serotonin signaling via gap junctions in regulating PASMC phenotype. The pathophysiological significance of this myoendothelial gap junction-dependent serotonin signaling is unknown, but it may be involved in the medial thickening and neomuscularization of hypertensive pulmonary arteries and arterioles. This novel signaling pathway may be particularly important in small, peripheral pulmonary arteries, where the ratio of PAECs to PASMCs is much higher than that in proximal pulmonary arteries with multiple layers of PASMCs.
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